Ulinastatin, a protease inhibitor, attenuates hepatic ischemia/reperfusion injury by downregulating TNF-alpha in the liver

Transplant Proc. 1998 Nov;30(7):3732-4. doi: 10.1016/s0041-1345(98)01214-7.
No abstract available

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Gene Expression Regulation / drug effects*
  • Glycoproteins / pharmacology*
  • Ischemia / metabolism
  • Ischemia / physiopathology*
  • Liver / blood supply*
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Neutrophils / physiology
  • Organ Preservation / methods*
  • Rats
  • Rats, Wistar
  • Reperfusion
  • Reperfusion Injury / prevention & control*
  • Thiobarbituric Acid Reactive Substances / analysis
  • Trypsin Inhibitors / pharmacology*
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Glycoproteins
  • Thiobarbituric Acid Reactive Substances
  • Trypsin Inhibitors
  • Tumor Necrosis Factor-alpha
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • urinastatin